Pharming milks cost benefits through Chinese alliance
This article was originally published in Scrip
Executive Summary
The flow of alliances between Chinese firms and Western partners involving technology and novel products continues, with Dutch firm Pharming the latest to enter into a broad partnership aimed at the cost-effective, high-quality manufacture of biologics in its portfolio and the commercialization of its lead product in China.